Chief, Division of Surgical Oncology
General Surgery
Dr. Michael S. Sabel, MD
|
|
Give Review
Michael S. Sabel, MD is an expert in the field of General Surgery. He went to medical school at Temple University School of Medicine. He over the years received 3 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Michael S. Sabel, MD is a published MD. He has 95 publications published. The most current publication "Defining the Relationship between Patient Decisions to Undergo Breast Reconstruction and Contralateral Prophylactic Mastectomy." Michael Sabel accepts Medicare payments and is registered with Medicare.gov.
Publications
- Defining the Relationship between Patient Decisions to Undergo Breast Reconstruction and Contralateral Prophylactic Mastectomy.
- Lobular neoplasia: morphology and management.
- Nonsurgical Ablation of Breast Cancer: Future Options for Small Breast Tumors.
- International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin.
- Predicting the development of brain metastases in patients with local/regional melanoma.
- Discordance in Histopathologic Evaluation of Melanoma Sentinel Lymph Node Biopsy with Clinical Follow-Up: Results from a Prospectively Collected Database.
- Individualized, patient-centered application of consensus guidelines to improve the quality of breast Cancer care.
- EZH2 expands Breast stem cells through activation of NOTCH1 signaling.
- Mutations in linker histone genes HIST1H1 B, C, D and E, OCT2 (POU2F2), IRF8 and ARID1A underlying the pathogenesis of follicular lymphoma.
- It is not always necessary to do axillary dissection for t1 and t2 breast Cancer--reply to point.
- The need for axillary lymph node dissection in t1/t2 breast Cancer surgery--counterpoint.
- Surgeons' Knowledge and Practices Regarding the Role of Radiation Therapy in Breast Cancer Management.
- Pediatric melanoma: Analysis of an international registry.
- Analytic morphometric assessment of patients undergoing colectomy for colon cancer.
- Intraoperative frozen section Analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical...
- Sentinel lymph node biopsy for thin melanoma-con.
- Is Duct Excision Still Necessary for All Cases of Suspicious Nipple Discharge?
- Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing bre...
- Is a level III dissection necessary for a positive sentinel lymph node in melanoma?
- Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma.
- Validation of Statistical Predictive Models Meant to Select Melanoma Patients for Sentinel Lymph Node Biopsy.
- Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
- Metastatic basal cell Carcinoma from a small tumor with lymphatic invasion.
- Sentinel lymph node biopsy for melanoma: one procedure but many questions: comment on "prognostic usefulness of sentinel lymph node biopsy for patients who have c...
- EZH2 and ALDH-1 mark breast epithelium at risk for breast Cancer development.
- Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast Cancer.
- Surgical considerations in early-stage breast Cancer: lessons learned and future directions.
- Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.
- Serum autoantibody profiling using a natural glycoprotein microarray for the prognosis of early melanoma.
- DermatofibroSarcoma protuberans: how wide should we resect?
- Lymphangiogenesis-independent resolution of experimental edema.
- Sentinel lymph node biopsy before or after neoadjuvant chemotherapy: pros and cons.
- Rate of freeze alters the immunologic response after cryoablation of breast Cancer.
- Obesity and angiolymphatic invasion in primary breast Cancer.
- Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
- Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
- Review of evidence-based support for pretreatment imaging in melanoma.
- Melanoma: do we need a hatchet or a scalpel?
- Residual disease after re-excision Lumpectomy for close margins.
- Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses.
- Determinants of breast conservation rates: reasons for mastectomy at a comprehensive Cancer center.
- Axillary staging prior to neoadjuvant chemotherapy for breast Cancer: predictors of recurrence.
- State of the science 60th anniversary review: 60 Years of advances in cutaneous melanoma epidemiology, diagnosis, and treatment, as reported in the journal Cancer.
- Epithelial and stromal cathepsin K and CXCL14 expression in Breast tumor progression.
- Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
- Obesity and Cancer treatment: weighing the evidence.
- Cryoablation for breast Cancer: no need to turn a cold shoulder.
- Translational research in melanoma.
- Sentinel lymph node biopsy for breast Cancer: how many nodes are enough?
- Generation of a tumor-specific systemic response after intratumoral injection of IL-12 and IL-18-loaded polylactic acid microspheres.
- Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
- Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast Cancer at presentation.
- Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast Cancer.
- What is a sentinel node? Re-evaluating the 10% rule for sentinel lymph node biopsy in melanoma.
- The changing profile of esophageal Cancer presentation and its implication for diagnosis.
- Surgical therapy of cutaneous melanoma.
- Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
- The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
- Adoptive immunotherapy of breast Cancer with lymph node cells primed by cryoablation of the primary tumor.
- Changes in surgical management resulting from case review at a breast Cancer multidisciplinary tumor board.
- Neoadjuvant intratumoral cytokine-loaded microspheres are superior to postoperative autologous cellular vaccines in generating systemic anti-tumor immunity.
- Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
- Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
- Allogeneic and autologous melanoma vaccines: where have we been and where are we going?
- Does the method of biopsy affect the incidence of sentinel lymph node metastases?
- The role of sentinel lymph node biopsy for melanoma: evidence assessment.
- Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after Breast-conservation therapy.
- Clinicopathologic features associated with having four or more metastatic axillary nodes in breast Cancer patients with a positive sentinel lymph node.
- Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-Analysis.
- A putative role for psoriasin in Breast tumor progression.
- Wide excision without radiation for desmoplastic melanoma.
- Nonsentinel node metastasis in breast Cancer patients: assessment of an existing and a new predictive nomogram.
- Protein kinase C epsilon is a predictive biomarker of aggressive breast Cancer and a validated target for RNA interference antiCancer therapy.
- Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.
- Is blue dye indicated for sentinel lymph node biopsy in breast Cancer patients with a positive lymphoscintigram?
- Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
- Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image Analysis.
- Patterns of Internet use and impact on patients with melanoma.
- Immunologic approaches to breast Cancer treatment.
- Small (< 2.0-cm) breast Cancers: mammographic and US findings at US-guided cryoablation--initial experience.
- Mastectomy and concomitant sentinel lymph node biopsy for invasive breast Cancer.
- Cryoablation of early-stage breast Cancer: work-in-progress report of a multi-institutional trial.
- Efficacy of sentinel lymph node biopsy in male breast Cancer.
- Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.
- Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast Cancer and systemic antitumor immunity.
- Point: Interferon-alpha for adjuvant therapy for melanoma patients.
- Clinicopathologic features of metastasis in nonsentinel lymph nodes of Breast carcinoma patients.
- EZH2 is a marker of aggressive breast Cancer and promotes neoplastic transformation of breast epithelial cells.
- Sentinel node biopsy prior to neoadjuvant chemotherapy.
- Melanoma: adjuvant therapy and other treatment options.
- Pros and cons of adjuvant interferon in the treatment of melanoma.
- Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor i...
- Esophageal resection for Carcinoma in patients older than 70 years.
- Melanoma vaccines: breakthrough or bust?
Schools
Temple University School Of Medicine
Rush Presby St Lukes Med Center
Roswell Park Canc Center
Procedures Preformed
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Biopsy of Breast
- Breast Reconstruction
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Appendicitis
- Breast Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Rush University Medical Center -
Temple University School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1306947221 | |
| NPPES Provider LastName | SABEL | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 481095916 | |
| NPPES Provider State | MI | |
| Specialty Description | General Surgery | |
| Total Claim Count | 66.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 26.0 | |
| Percent Opioid Claims | 39.39 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306947221 |
| Last Name Of The Provider | SABEL |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Alisha Arora, MD |
|
|
Dr. Lisa M. Colletti, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vincent M. Cimmino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin D. Carr, MD |
|
|
Dr. Rebecca M. Minter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susanne G. Carpenter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tyler R. Grenda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura R. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jae W. Song, MD |
|
|
Dr. Iris H. Wei, MD |